skip to the content

Clinical Trials

Chemotherapy - Peripheral Neuropathy Study

URCC 07004: Assessment Of Topical Treatment Response With Amitriptyline And Ketamine: Combination Trial In Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)

Protocol ID

07.06.122

Protocol Description

The purpose of this study is to determine if a cream called EpiCept-NP-1® is effective, safe and tolerable when applied to the skin of people with chemotherapy-associated peripheral neuropathy.

Eligibility Criteria

Patients undergoing chemotherapy

Primary Investigator(s)

  • James D'Olimpio, MD

Contact Information

Nanette Nier, RN
(516) 734-8918
nnier@nshs.edu

Last Update

March 26, 2010
top
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Cancer:
top
top